54.47
前日終値:
$54.20
開ける:
$54.2
24時間の取引高:
438.40K
Relative Volume:
0.39
時価総額:
$2.31B
収益:
-
当期純損益:
$-63.78M
株価収益率:
-20.32
EPS:
-2.68
ネットキャッシュフロー:
$-53.91M
1週間 パフォーマンス:
-0.24%
1か月 パフォーマンス:
+26.29%
6か月 パフォーマンス:
+447.99%
1年 パフォーマンス:
+248.94%
Celcuity Inc Stock (CELC) Company Profile
CELC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CELC
Celcuity Inc
|
54.47 | 2.27B | 0 | -63.78M | -53.91M | -2.68 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-01 | 再開されました | Stifel | Buy |
2024-07-22 | 開始されました | Leerink Partners | Outperform |
2024-02-22 | 開始されました | Stifel | Buy |
2023-12-08 | 開始されました | H.C. Wainwright | Buy |
2021-10-08 | 開始されました | Canaccord Genuity | Buy |
2021-09-07 | 開始されました | Jefferies | Buy |
2021-07-29 | 開始されました | Cowen | Outperform |
2021-07-27 | 開始されました | Needham | Buy |
2021-01-28 | 繰り返されました | H.C. Wainwright | Buy |
2020-12-24 | 繰り返されました | H.C. Wainwright | Buy |
2020-05-11 | 再開されました | Craig Hallum | Buy |
2018-11-20 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Celcuity Inc (CELC) 最新ニュース
Volume spikes in Celcuity Inc. stock – what they meanExit Point & Consistent Return Investment Signals - Newser
Using data tools to time your Celcuity Inc. exitJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
Should you wait for a breakout in Celcuity Inc.Bond Market & Reliable Price Breakout Signals - Newser
Leading vs lagging indicators on Celcuity Inc. performanceJuly 2025 Movers & AI Optimized Trade Strategies - Newser
Celcuity (CELC) Is Up 7.2% After FDA Accepts Gedatolisib NDA for Advanced Breast Cancer Approval - simplywall.st
Forecasting Celcuity Inc. price range with options dataTrade Signal Summary & High Win Rate Trade Tips - Newser
What recovery options are there for Celcuity Inc.Market Growth Review & Community Consensus Trade Signals - Newser
Is Celcuity Inc. showing signs of accumulation2025 Earnings Surprises & Proven Capital Preservation Methods - Newser
Is this a good reentry point in Celcuity Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - Newser
What is the cash position of Celcuity Inc.July 2025 Retail & Weekly Top Gainers Alerts - khodrobank.com
Sentiment analysis tools applied to Celcuity Inc.Dividend Hike & Weekly Momentum Picks - Newser
Is it time to cut losses on Celcuity Inc.July 2025 Review & Weekly Breakout Watchlists - Newser
Will Celcuity Inc. benefit from rate cutsStop Loss & Weekly High Return Stock Forecasts - khodrobank.com
Buy Signal: What is Celcuity Inc.’s valuation compared to sectorInsider Buying & Weekly Momentum Picks - khodrobank.com
Can Celcuity Inc. be recession proof2025 Sector Review & Growth Focused Investment Plans - خودرو بانک
What to do if you’re stuck in Celcuity Inc.Volume Spike & Community Trade Idea Sharing - Newser
Key metrics from Celcuity Inc.’s quarterly dataMarket Performance Summary & Daily Entry Point Alerts - Newser
How to forecast Celcuity Inc. trends using time series2025 Support & Resistance & Fast Gaining Stock Reports - Newser
Smart tools for monitoring Celcuity Inc.’s price action2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Using Python tools to backtest Celcuity Inc. strategiesTrade Analysis Report & Free Expert Approved Momentum Trade Ideas - Newser
Will Celcuity Inc. outperform during market ralliesJuly 2025 Short Interest & Stepwise Trade Execution Plans - khodrobank.com
Will Celcuity Inc. continue its uptrendPortfolio Value Summary & Consistent Profit Trading Strategies - Newser
Combining machine learning predictions for Celcuity Inc.Weekly Investment Summary & High Conviction Buy Zone Alerts - Newser
Celcuity Inc. Q2 Earnings Call: Progress in Clinical Trials and Financial Strengthening Amid Increased Losses and Expenses. - AInvest
Relative strength of Celcuity Inc. in sector analysisGold Moves & AI Forecast for Swing Trade Picks - Newser
Celcuity Inc. stock momentum explainedWeekly Profit Report & Growth Focused Entry Reports - Newser
Celcuity Inc. Earnings Call: Clinical Progress and Financial Fortification - MSN
What technical models suggest about Celcuity Inc.’s comebackQuarterly Profit Report & Real-Time Volume Analysis - Newser
Celcuity Shares Soar After FDA Accepts Gedatolisib NDA for Review - MSN
How to recover losses in Celcuity Inc. stockWeekly Risk Report & Community Consensus Picks - Newser
Heatmap analysis for Celcuity Inc. and competitors2025 Performance Recap & Technical Entry and Exit Alerts - Newser
Is it time to cut losses on Celcuity IncJuly 2025 Pullbacks & Capital Protection Trading Alerts - Newser
Will Celcuity Inc. bounce back from current support2025 Technical Patterns & Smart Investment Allocation Tips - Newser
How to build a dashboard for Celcuity Inc. stockWeekly Stock Analysis & Community Verified Trade Signals - Newser
Does Celcuity Inc. show high probability of reboundJuly 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Using data filters to optimize entry into Celcuity Inc.Market Performance Recap & Breakout Confirmation Alerts - Newser
Celcuity Inc (CELC) 財務データ
収益
当期純利益
現金流量
EPS
Celcuity Inc (CELC) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Dalvey David | Director |
Jul 28 '25 |
Sale |
45.12 |
9,325 |
420,767 |
0 |
大文字化:
|
ボリューム (24 時間):